---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-011342"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:38:40.571263+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Anebulo plans going-private via reverse split; $3.50/share for fractional shares, 91% premium

## Summary
- Reverse stock split ratio range 1-for-2,500 to 1-for-7,500; stockholder vote at special meeting Aug 22, 2025.
- Cash payment of $3.50 per pre-split share for fractional shares, representing a 91% premium to July 22 close.
- Holders below 2,500-7,500 pre-split shares will be cashed out; holders above retain one post-split share per minimum.
- Transaction aims to reduce record holders below 300 to terminate SEC registration; board may abandon at any time.
- Company cites high cost of being public as burdensome; will focus on advancing selonabant IV formulation.

## SEC filing metadata
- accession: 0001493152-25-011342
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315225011342/0001493152-25-011342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315225011342/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-011342
- JSON: https://secwatch.observer/filing/0001493152-25-011342.json
- Plain text: https://secwatch.observer/filing/0001493152-25-011342.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.